Sequential assessments of KRAS-mutated circulating tumor DNA in longitudinal monitoring enable the prediction of prognosis and therapeutic responses in patients with pancreatic cancer.

被引：1
|
作者：
Watanabe, Fumiaki
Suzuki, Koichi
Tamaki, Sawako
Ishikawa, Hideki
Kakizawa, Nao
Noda, Hiroshi
Rikiyama, Toshiki
机构：
[1] Jichi Med Univ, Saitama, Japan
[2] Jichi Med Univ, Saitama Med Ctr, Saitama, Japan
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2019年 / 37卷 / 15期
关键词：
D O I：
10.1200/JCO.2019.37.15_suppl.e15712
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e15712
引用
收藏
页数：1
相关论文
共 50 条
  • [21] Quantitative monitoring of circulating tumor DNA in patients with advanced pancreatic cancer undergoing chemotherapy
    Sugimori, Makoto
    Sugimori, Kazuya
    Tsuchiya, Hiromi
    Suzuki, Yoshimasa
    Tsuyuki, Sho
    Kaneta, Yoshihiro
    Hirotani, Akane
    Sanga, Katsuyuki
    Tozuka, Yuichiro
    Komiyama, Satoshi
    Sato, Takeshi
    Tezuka, Shun
    Goda, Yoshihiro
    Irie, Kuniyasu
    Miwa, Haruo
    Miura, Yuuki
    Ishii, Tomohiro
    Kaneko, Takashi
    Nagahama, Masatsugu
    Shibata, Wataru
    Nozaki, Akito
    Maeda, Shin
    CANCER SCIENCE, 2020, 111 (01) : 266 - 278
  • [22] Dynamics and characteristics of KRAS mutated circulating tumor DNA in patients with metastatic colorectal cancer during various treatments.
    Takayama, Yuji
    Suzuki, Koichi
    Ichida, Kosuke
    Fukui, Taro
    Kakizawa, Nao
    Watanabe, Fumiaki
    Kikugawa, Rina
    Hasegawa, Fumi
    Tsujinaka, Shingo
    Miyakura, Yasuyuki
    Konishi, Fumio
    Rikiyama, Toshiki
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (04)
  • [23] Driver Mutation Variant Allele Frequency in Circulating Tumor DNA and Association with Clinical Outcome in Patients with Non-Small Cell Lung Cancer and EGFR- and KRAS-Mutated Tumors
    Li, Meijuan
    Yang, Lei
    Hughes, Jason
    van den Hout, Allison
    Burns, Christine
    Woodhouse, Ryan
    Dennis, Lucas
    Hegde, Priti
    Oxnard, Geoffery R.
    Vietz, Christine
    JOURNAL OF MOLECULAR DIAGNOSTICS, 2022, 24 (05): : 543 - 553
  • [24] Urinary measurement of circulating tumor DNA for treatment monitoring and prognosis of metastatic colorectal cancer patients
    Song, Tao
    Mao, Fei
    Shi, Li
    Xu, Xuemei
    Wu, Zirong
    Zhou, Juan
    Xiao, Meifang
    CLINICAL CHEMISTRY AND LABORATORY MEDICINE, 2019, 57 (02) : 268 - 275
  • [25] Circulating tumor DNA methylation profiles enable early diagnosis, prognosis prediction, and screening for colorectal cancer (Publication with Expression of Concern)
    Luo, Huiyan
    Zhao, Qi
    Wei, Wei
    Zheng, Lianghong
    Yi, Shaohua
    Li, Gen
    Wang, Wenqiu
    Sheng, Hui
    Pu, Hengying
    Mo, Haiyu
    Zuo, Zhixiang
    Liu, Zexian
    Li, Chaofeng
    Xie, Chuanbo
    Zeng, Zhaolei
    Li, Weimin
    Hao, Xiaoke
    Liu, Yuying
    Cao, Sumei
    Liu, Wanli
    Gibson, Sarah
    Zhang, Kang
    Xu, Guoliang
    Xu, Rui-hua
    SCIENCE TRANSLATIONAL MEDICINE, 2020, 12 (524)
  • [26] Serial monitoring of circulating tumor DNA in patients with metastatic colorectal cancer to predict the therapeutic response
    Zhou, J.
    Bai, C.
    Sun, Z.
    Cheng, Y.
    Jia, N.
    Zhou, Y.
    ANNALS OF ONCOLOGY, 2018, 29
  • [27] Serial Monitoring of Circulating Tumor DNA in Patients With Metastatic Colorectal Cancer to Predict the Therapeutic Response
    Jia, Ning
    Sun, Zhao
    Gao, Xin
    Cheng, Yuejuan
    Zhou, Yanping
    Shen, Chunying
    Chen, Wei
    Wang, Xueliang
    Shi, Rong
    Li, Nan
    Zhou, Jianfeng
    Bai, Chunmei
    FRONTIERS IN GENETICS, 2019, 10
  • [28] Longitudinal HER2 amplification tracked in circulating tumor DNA for therapeutic effect monitoring and prognostic evaluation in patients with breast cancer
    Guan, Xiuwen
    Liu, Binliang
    Niu, Yunyun
    Dong, Xin
    Zhu, Xia
    Li, Chunxiao
    Li, Lixi
    Yi, Zongbi
    Sun, Xiaoying
    Chen, Hongyan
    Lu, Sijia
    Ma, Fei
    BREAST, 2020, 49 : 261 - 266
  • [29] Longitudinal HER2 amplification tracked in circulating tumor DNA for therapeutic effect monitoring and prognostic evaluation in patients with breast cancer
    Guan, X.
    Niu, Y.
    Liu, B.
    Li, C.
    Li, L.
    Yi, Z.
    Sun, X.
    Chen, H.
    Ma, F.
    Lu, S.
    ANNALS OF ONCOLOGY, 2019, 30
  • [30] Diagnostic and Prognostic Values of KRAS Mutations on EUS-FNA Specimens and Circulating Tumor DNA in Patients With Pancreatic Cancer
    Wang, Ronghua
    Zhao, Yuchong
    Wang, Yun
    Zhao, Zhenxiong
    Chen, Qian
    Duan, Yaqi
    Xiong, Si
    Luan, Zhou
    Wang, Jinlin
    Cheng, Bin
    CLINICAL AND TRANSLATIONAL GASTROENTEROLOGY, 2022, 13 (05)
12345